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Abstract
Background: Human immunodeficiency virus (HIV) infection and antiretroviral treatment are associated with
metabolic and cardiovascular complications that potentially increase the risk of atherosclerosis and cardiovascular
disease in this population. Measurement of arterial wall thickness has been used as a surrogate of extent, severity
and progression of atherosclerosis. A cross-sectional cohort study was performed to compare the validity of two
non-invasive arterial measures: carotid intima-media thickness (IMT), a parameter of atherosclerosis, and ophthalmic
artery resistance index (OARI), an index of occlusive carotid artery disease.
Methods: A total of 95 patients receiving highly active antiretroviral therapy (HAART) for more than 12 months
were consecutively enrolled. IMT and OARI were measured by 7.5 MHz linear probe.
Results: There was a significant linear increase in IMT and OARI values as the grade of cardiovascular risk (0.70 and
0.69 for very low risk, 0.86 and 0.72 for low risk and 0.98 and 0.74 for medium/high risk, p < 0.001). A IMT > 0.83
and an OARI > 0.72 were the most discriminatory values for predicting a cardiovascular risk ≥ 10% (sensibility
89.6% and 75.8%; sensitivity 70.5% and 68.4%; p < 0.001).
Conclusions: Our data indicate that OARI may have a potential as a new precocious marker of subclinical
atherosclerosis in HIV-1-infected patients.
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Background
The introduction of highly active antiretroviral therapy
(HAART) has dramatically changed the prognosis of
human immunodeficiency virus (HIV) infection [1]. In
this scenario, cardiovascular diseases have gained impor-
tance as possible causes of morbidity and mortality
[2,3]. Cardiovascular disease is often correlated to the
development of atherosclerosis with plaque formation
on arterial walls [4].
Measurement of arterial wall thickness has been used
as a surrogate of extent, severity and progression of
atherosclerosis [5]. Carotid intima-media thickness
(IMT) is a measure of anatomic disease and a significant
predictor of acute coronary events [5,6] associated with
cardiovascular risk factors [5,7,8].
Moreover, carotid IMT is associated with cardiovascu-
lar disease (CVD) risk factors, prevalent CVD, incident
CVD and the degree of atherosclerosis [9-12]. These
observations support the concept that carotid IMT mea-
surement could be used as a surrogate marker of
atherosclerosis.
The ophthalmic artery (OA) is the first major branch
of the internal carotid artery, so changes in OA blood
flow have provided insight into various vascular disor-
ders, including carotid artery stenosis [13]. OA Doppler
has anatomical advantages due to the absence of
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sclerosis, with previous data showing correlation
between alterations of the OA and systemic cardiovascu-
lar disease [14,15].
There are limited data on the relationship between
carotid IMT or OA blood flow and cardiovascular risk
factors in HIV patients [16].
Therefore, the aim of this study is to investigate
whether OA Doppler imaging could have clinical poten-
tial for evaluating the severity of cardiovascular risk in
HIV-1+ infected patients, with a better reproducibility
than IMT assessment.
Methods
This study was approved by the local institutional Ethics
Committee and all patients approached for the study
gave written consent to participate.
HIV-1-infected patients referred to our outpatient
center between 1 January and 31 June 2009 were con-
sidered for this study. Inclusion criteria were: age 18-70
years, proven HIV-1 infection, and receiving HAART
for more than 12 months. Exclusion criteria were: active
AIDS defining illness, diabetes mellitus, active drug
abuse, alcohol abuse (defined as alcohol consumption of
more than 30 gr/day). Patients requiring systemic che-
motherapy, radiation therapy or systemic steroids were
excluded). An in-depth assessment was performed,
including HIV disease history, other co-morbid condi-
tions, medication exposure and measurement of blood
pressure (determined using a sphygmomanometer with
the subjects at rest in a sitting position). Smokers were
defined as individuals smoking more than 5 cigarettes/
day at least during the past year (in our cohort all the
patients who smoked declared they smoked > 5 cigar-
ettes/day). CD4+ cell counts, HIV RNA load, total
serum cholesterol level, high-density lipoprotein (HDL)
cholesterol level, glucose and triglyceride levels were
evaluated at baseline after a 12-h overnight fast. In all
patients the 10-year risk of having a heart attack was
estimated by the Framingham equation (available at the
following on-line address: http://hp2010.nhlbihin.net/
atpiii/calculator.asp). Patients were classified as very low,
low, or medium/high risk if Framingham risk scores
were < 5%, 5-9% and ≥ 10% respectively [17].
For ultrasound measurement of IMT and OARI a
Logiq 5 ultrasound scanner (General Electric Medical
Systems, Wallingford, Connecticut, USA) was used.
S o n o g r a p h i ce v a l u a t i o n sw e r ep e r f o r m e db yas i n g l e
trained sonographer blinded to the patients’ data. The
patients lay supine in a quiet, dark room. The right and
left common carotid arteries were examined with the
head in the midline position tilted slightly upward.
A 7.5 MHz linear probe was used. The probe was placed
so that the near and far walls were parallel to it and
lumen diameter was maximized in the longitudinal
plane. The IMT was defined as the distance between the
media-adventitia interface and the lumen-intima inter-
face and was measured at about 1 cm proximal to the
bifurcation of the common carotid artery. Two parallel
echogenic lines separated by an anechoic space can be
visualized in the anterior wall of the carotid (Figure 1A).
OARI was measured with the patient lying supine with
eyes closed, using an ultrasound frequency of 7.5 MHz
and by averaging the readings from at least three conse-
cutive waveforms. The transducer was applied to the
closed upper eyelid using a thick layer of acoustic gel,
minimizing the pressure on the globe (Figure 1B).
The reproducibility of IMT and OARI measurement
was evaluated by triple determinations in 20 subjects
other than the enrolled patients.
Continuous variables were reported as the mean ±
standard deviation (SD) and categorical factors were
reported as percentages. One-way analysis of variance
(ANOVA) models were used to examine differences in
carotid IMT or OARI by Framingham risk group classi-
fication. Multiple regression analysis was used to assess
Figure 1 IMT and OARI measurement. (A) Common carotid intima-media thickness. Longitudinal scan obtained at 1 cm proximal to the origin
of the carotid bulb shows the IMT (arrows). (B) Ophtalmic artery resistence index. Both measurements were evaluated by ultrasound frequency
of 7.5 mHz.
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OARI and traditional Framingham cardiovascular risk
factors of age, male gender, current smoking status, sys-
tolic blood pressure, total and HDL cholesterol. The
most discriminant cutoffs were calculated by receiver
operating characteristic (ROC) curves.
We evaluated the relationship between carotid IMT
and OARI using the Pearson correlation co-efficient.
Statistical calculations were performed with MedCalc
software, version 11.4.1.0. A p-value < 0.05 was consid-
ered to be statistically significant.
Results
Ninety-five patients (74 men and 21 women; mean age
45.2 ± 8.6 years; range 23-70 years) were recruited
between January 1 and June 31, 2009. Demographic, epi-
demiological, clinical, metabolic and ultrasonographic
characteristics of patients are shown in Table 1. Table 2
shows different antiretroviral drugs used by our study
population. There were 75 (78.9%) patients treated with
Tenofovir, 12 (12.6%) with Abacavir and Lamivudine, and
76 (80%) with Emtricitabine. Non-nucleoside reverse
transcriptase inhibitor (NNRTIs) therapy included Efavir-
enz in 36 (37.8%) patients and Nevirapine in 12 (12.6%)
patients. Protease inhibitors (PI) included Lopinavir/Rito-
navir in 5 (5.2%) patients, Darunavir/Ritonavir in 16
(16.8%), Atazanavir/Ritonavir in 13 (13.6%) and Atazanavir
without Ritonavir in 4 (4.2%). There were 2 (2.1%) patients
treated with Maraviroc and 10 (10.5%) with Raltegravir.
We found a significant positive correlation between IMT
and OARI (r = 0.66, p < 0.0001; Figure 2).
We obtained a good reproducibility of IMT (ICC =
0.90; 95% CI 0.81 -0.95 for single measures and ICC =
0.96; 95% CI 0.92 -0.98 for average measures) and OARI
(ICC = 0.94; 95% CI 0.89-0.97 for single measures and
ICC = 0.98; 95% CI 0.86-0.99 for average measures).
Stratifying by Framingham risk group, there was a sig-
nificant linear increase of carotid IMT or OARI as the
risk group classification (Table 3). Carotid IMT and
OARI differed significantly between risk groups from
ANOVA analysis (p < 0.001) (Figure 3). Using carotid
IMT or OARI as the dependent variable in regression
analysis, age (r:0.57, p < 0.0001 and r:0.57, p < 0.0001
respectively), current smoking status (r:0.44, p < 0.01
and r:0.30, p < 0.05 respectively) and systolic pressure
(r:0.48, p < 0.01 and r:0.36, p < 0.05 respectively) were
independent factors associated with IMT and OARI.
Neither total cholesterol nor HDL cholesterol were sta-
tistically significantly associated with IMT or OARI.
ROC curves indicated that the most discriminant IMT
or OARI value for predicting a medium/high cardiovas-
cular risk was > 0.83 mm (sensitivity 89.6%, specificity
70.5%, AUC 0.84, Standard error 0.04, p < 0.0001) and
> 0.72 (sensitivity 75.8%, specificity 68.3%, AUC 0.73,
Standard error 0.06, p < 0.001) respectively. There was
no statistically significant difference between IMT and
Table 1 Demographic, clinical, metabolic and
ultrasonographic characteristics of HIV-1-infected
patients
Variable Estimate
Age (years) 45.2 ± 8.6
Sex (M/F) 74/21
Current smoker 50 (52.6%)
Systolic pressure (mmHg) 121 ± 15
HIV exposure
Homosexual 32 (33.6%)
Heterosexual 34 (35.7%)
IDU 28 (29.47%)
HCV co-infection 25 (26%)
CD4 count (cells/ml) 525.7 ± 249.7
CD4 percentage (%) 27.5 ± 10.7
CD4 nadir count (cells/ml) 208.8 ± 120
CD4 nadir percentage (%) 17.6 ± 7.9
HIVRNA load (log10 copies) 1.5 ± 0.8
Duration of HIV infection (years) 10.3 ± 7.8
Duration of HAART (months) 76.8 ± 46.2
Total cholesterol (mg/dl) 179.9 ± 46.1
HDL cholesterol (mg/dl) 45.8 ± 12.9
Glucose (mg/dl) 97.3 (21.2)
Right common carotid IMT (mm) 0.83 ± 0.21
Left common carotid IMT (mm) 0.85 ± 0.21
Right OARI 0.70 ± 0.04
Left OARI 0.71 ± 0.04
IDU, intravenous drug users; HAART, highly active antiretroviral therapy; HDL,
high density lipoprotein; IMT, intima-media thickness; OARI, ophthalmic artery
resistance index. All data are expressed as mean ± standard deviation. A p-
value of < 0.05 was considered to be statistically significant.
Table 2 Antiretroviral treatment used in ninety-five HIV-
1-infected patients
Antiretroviral drugs Number of patients (%)
TDF 75 (78.9)
ABC 12 (12.6)
3TC 12 (12.6)
FTC 76 (80)
NVP 12 (12.6)
EFV 36 (37.8)
LPV/RTV 5 (5.2)
ATV/RTV 13 (13.6)
ATV 4 (4.2)
DRV/RTV 16 (16.8)
RAL 10 (10.5)
MVC 2 (10.5)
TDF, tenofovir; ABC, abacavir; 3TC, lamivudine; FTC, emtricitabine; NVP,
nevirapine; EFV, efavirenz; LPV/RTV, lopinavir/ritonavir; ATV/RTV, atazanvir/
ritonavir; DRV/RTV, darunavir/ritonavir; RAL, raltegravir; MVC, maraviroc. All
data are expressed as number (%) of patients.
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p = 0.12)
Discussion
Several reports have shown that HIV-1-infected patients
have an increased risk of cardiovascular disease [18,19].
Ultrasound may be an important step towards selecting
patients at medium/high risk for developing cardiovascular
disease, allowing early intervention, and thus minimizing
the impact of clinical complications resulting from this
condition. Measurement of carotid IMT by ultrasonogra-
phy is a well established method for assessing sub-clinical
atherosclerosis in the HIV-negative population and it is
the only non-invasive imaging recommended by the
American Heart Association for inclusion in risk assess-
ment for cardiovascular disease [20]. The manual mea-
surement of IMT is the most common technique used in
clinical practice, even though it is time-consuming and the
results from these readings may be biased by the lack of
expertise or by some subjective judgment of the observer.
Thus, automated measurement procedures have been
developed [21,22]. The development of automated meth-
ods for measuring IMT in standard ultrasound equipment
has contributed importantly to better reproducibility of
results between different observers as well as reducing
considerably the time needed for image evaluation. How-
ever, the mean difference between the automated and
manual methods for IMT measurement was not clinically
relevant in any of the carotid segments evaluated in the
majority of cases, and carries no systematic errors [23].
On the other hand, the automated method also
enables us to reliably compare online data with other
previously published reports for different populations in
percentiles, as recently proposed by the American
Society of Echocardiography [24].
IMT values correlate well with pathological measure-
ments and are potent predictors of myocardial infarction
and stroke. For each 0.1 mm increase in common caro-
tid IMT the risk of acute myocardial infarction increases
by 11% [9].
IMT is a feature of arterial wall aging that is not
synonymous with subclinical atherosclerosis, but is
related to it because the cellular and molecular altera-
tions that underlie intima-media thickening have been
implicated in the development, progression, or both of
atherosclerosis [24].
The ophthalmic artery is the first major branch of the
internal carotid artery, and changes in blood flow have
Figure 2 Linear regression curve of relation between IMT and OARI. Dotted line, 95% confidence interval; IMT, intima-media thickness; OARI,
ophthalmic artery resistance index.
Table 3 Characteristics for data by Framingham risk
group
Characteristics A (n = 37) B (n = 23) C (n = 35) p-value
IMT (mm) 0.70 ± 0.2 0.86 ± 0.21 0.98 ± 0.2 < 0.0001*
OARI (mm) 0.69 ± 0.05 0.72 ± 0.04 0.74 ± 0.04 < 0.001**
A, very low cardiovascular risk (< 5%); B, low cardiovascular risk (5%-9%); C,
medium/high cardiovascular risk (≥ 10%). IMT, intima-media thickness; OARI,
ophthalmic artery resistance index. Data are expressed as mean ± standard
deviation. *A vs B and B vs C; ** A vs B. A p-value of < 0.05 was considered to
be statistically significant.
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including carotid artery stenosis and metabolic disorders
[17,25]. Orbital circulation changes with varying degrees
of carotid stenosis [26] were observed, with a significant
relation between orbital velocity changes and carotid
occlusive disease [27]. Studies on carotid artery stenosis
have shown decreased blood flow velocity in the
ophthalmic artery when the stenosis was greater than
70% [28], showing that measurement of orbital vessel
velocity may be essential for evaluating the distal conse-
quences of carotid artery stenosis [13].
Although carotid artery ultrasound evaluation is accu-
rate for diagnosis of carotid stenosis, additional images
may provide further information on the hemodynamics
of the internal carotid artery, including the velocities
and pulsatility indices of the orbital arteries, which may
reflect the hemodynamics of proximal carotid stenosis,
the flow direction of the ophthalmic artery and the pos-
sibility of a hemodynamically significant lesion distal to
the bifurcation of the carotid artery [25].
Delineating the direction of flow in the ophthalmic
artery is important in the assessment of patients with
cerebrovascular disease and may enhance our under-
standing of the pathogenesis of stroke [25].
OARI offers important advantages due to the
absence of ultrasound obstacles and the vertical angle,
which differs from the parallel-signaling of the carotid
artery [29].
Furthermore, it may provide information on the
hemodynamics of the internal carotid artery and orbital
arteries [25] and it has clinical potential for the evalua-
tion of the severity of coronary artery disease (CAD).
High levels of OARI seem to reflect diminished arterial
compliance caused by systemic atherosclerosis [29].
We used the manual method of IMT assessment
according to the most of the studies on IMT evaluation
in HIV-1 infected population, to reliably compare data
with other published reports. Moreover, as previously
demonstrated, we had low intra-observer variability for
IMT ultrasonographic measurements [16,30]
Our results regarding the relationship between OARI
and atherosclerosis are similar to data of a study [31]
that showed the association of ophthalmic artery Dop-
pler flow with systemic arterial compliance. It was
shown that a high grade of coronary atherosclerosis is
associated with decreased distensibility and loss of elas-
tic inhomogeneity of arteries, resulting in increased
pulse wave velocity [32].
In this study we found that OARI could be a clinically
significant indicator of medium/high cardiovascular risk
in HIV-1 infected patients with low intra-operator varia-
bility, reflecting vascular resistance resulting from ather-
osclerotic functional changes.
OARI evaluations may be an important step towards
selecting patients with significant risk for developing
cardiovascular disease, allowing early intervention.
Figure 3 Characteristics for data by Framingham risk group. White bar, very low cardiovascular risk (< 5%); grey bar, low cardiovascular risk
(5-9%); dotted bar, medium/high cardiovascular risk (≥ 10%); black lines, Standard deviation; IMT, intima-media thickness; OARI, ophthalmic artery
resistance index. * p < 0.0001; **p < 0.01.
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To our knowledge, this is the first study to compare
OARI and IMT in order to show that OARI could be
considered a surrogate of cardiovascular risk in HIV-1-
infected patients.
OARI provides further hemodynamic information and
it could be used to complement ultrasonographic assess-
ment of atherosclerosis. Examination of the orbital
arteries with color-coded Doppler imaging is a simple,
rapid, reproducible and non-invasive method.
Moreover, ophthalmic artery Doppler imaging has a
potential role in assessing the severity of cardiovascular
diseases.
As this study used a cross-sectional design, prospec-
tive designed studies might demonstrate further clinical
value of OARI, such as the predictive diagnosis of cor-
onary artery disease in patients with multiple risk
factors.
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